Outcomes of Maximal Conventional Therapy Before Biological Treatment in Recurrent Chronic Rhinosinusitis With Nasal Polyps
Topan YE, Bayar Muluk N, Yavuz R, Alataş N, Cingi C
J Craniofac Surg · 2026
Grade Ccohortn=42
Key Findings
- ●MCT improved SNOT-22 in ~70% of recurrent CRSwNP patients after prior ESS
- ●Only 13% of patients required biologics after structured MCT protocol
- ●Structured pre-biologic evaluation can identify true biologic candidates
Referenced in (1 disease)
ID: pmid-41842750DOI: 10.1097/SCS.0000000000012616PMID: 41842750